Open- | Close- |
Vol / Avg.30.000 / 331.941K | Mkt Cap3.986M |
Day Range- - - | 52 Wk Range0.462 - 10.390 |
Kiora Pharmaceuticals Stock (NASDAQ: KPRX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.30.000 / 331.941K | Mkt Cap3.986M |
Day Range- - - | 52 Wk Range0.462 - 10.390 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.060 | -0.790 | 0.2700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-24 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-08-14 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Lowers | 7.00 | 2.00 |
2023-08-09 | Maxim Group | Michael Okunewitch | Maintains | BuyBuy | Lowers | 12.00 | 2.00 |
2023-05-12 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Raises | 6.00 | 7.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
KPRX | Kiora Pharmaceuticals | 0% | 4M |
BXRX | Baudax Bio | 0% | 3.1M |
SXTP | 60 Degrees | 0% | 4.9M |
UPC | Universe Pharmaceuticals | 0% | 4.9M |
AKAN | Akanda | 0% | 2.3M |
You can purchase shares of Kiora Pharmaceuticals (NASDAQ: KPRX) through any online brokerage.
Other companies in Kiora Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN) and Jaguar Health (NASDAQ:JAGX).
The latest price target for Kiora Pharmaceuticals (NASDAQ: KPRX) was reported by HC Wainwright & Co. on Thursday, August 24, 2023. The analyst firm set a price target for 2.00 expecting KPRX to rise to within 12 months (a possible 263.64% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $0.55 last updated September 20, 2023 at 7:59 PM UTC.
There is no dividend information for Kiora Pharmaceuticals.
Kiora Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Kiora Pharmaceuticals.
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Kiora Pharmaceuticals Stock (NASDAQ: KPRX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.30.000 / 331.941K | Mkt Cap3.986M |
Day Range- - - | 52 Wk Range0.462 - 10.390 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.060 | -0.790 | 0.2700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-24 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-08-14 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Lowers | 7.00 | 2.00 |
2023-08-09 | Maxim Group | Michael Okunewitch | Maintains | BuyBuy | Lowers | 12.00 | 2.00 |
2023-05-12 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Raises | 6.00 | 7.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
KPRX | Kiora Pharmaceuticals | 0% | 4M |
BXRX | Baudax Bio | 0% | 3.1M |
SXTP | 60 Degrees | 0% | 4.9M |
UPC | Universe Pharmaceuticals | 0% | 4.9M |
AKAN | Akanda | 0% | 2.3M |
You can purchase shares of Kiora Pharmaceuticals (NASDAQ: KPRX) through any online brokerage.
Other companies in Kiora Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN) and Jaguar Health (NASDAQ:JAGX).
The latest price target for Kiora Pharmaceuticals (NASDAQ: KPRX) was reported by HC Wainwright & Co. on Thursday, August 24, 2023. The analyst firm set a price target for 2.00 expecting KPRX to rise to within 12 months (a possible 263.64% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $0.55 last updated September 20, 2023 at 7:59 PM UTC.
There is no dividend information for Kiora Pharmaceuticals.
Kiora Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Kiora Pharmaceuticals.
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Kiora Pharmaceuticals Stock (NASDAQ: KPRX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.30.000 / 331.941K | Mkt Cap3.986M |
Day Range- - - | 52 Wk Range0.462 - 10.390 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.060 | -0.790 | 0.2700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-24 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-08-14 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Lowers | 7.00 | 2.00 |
2023-08-09 | Maxim Group | Michael Okunewitch | Maintains | BuyBuy | Lowers | 12.00 | 2.00 |
2023-05-12 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Raises | 6.00 | 7.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
KPRX | Kiora Pharmaceuticals | 0% | 4M |
BXRX | Baudax Bio | 0% | 3.1M |
SXTP | 60 Degrees | 0% | 4.9M |
UPC | Universe Pharmaceuticals | 0% | 4.9M |
AKAN | Akanda | 0% | 2.3M |
You can purchase shares of Kiora Pharmaceuticals (NASDAQ: KPRX) through any online brokerage.
Other companies in Kiora Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN) and Jaguar Health (NASDAQ:JAGX).
The latest price target for Kiora Pharmaceuticals (NASDAQ: KPRX) was reported by HC Wainwright & Co. on Thursday, August 24, 2023. The analyst firm set a price target for 2.00 expecting KPRX to rise to within 12 months (a possible 263.64% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $0.55 last updated September 20, 2023 at 7:59 PM UTC.
There is no dividend information for Kiora Pharmaceuticals.
Kiora Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Kiora Pharmaceuticals.
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Kiora Pharmaceuticals Stock (NASDAQ: KPRX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.30.000 / 331.941K | Mkt Cap3.986M |
Day Range- - - | 52 Wk Range0.462 - 10.390 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.060 | -0.790 | 0.2700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-24 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-08-14 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Lowers | 7.00 | 2.00 |
2023-08-09 | Maxim Group | Michael Okunewitch | Maintains | BuyBuy | Lowers | 12.00 | 2.00 |
2023-05-12 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Raises | 6.00 | 7.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
KPRX | Kiora Pharmaceuticals | 0% | 4M |
BXRX | Baudax Bio | 0% | 3.1M |
SXTP | 60 Degrees | 0% | 4.9M |
UPC | Universe Pharmaceuticals | 0% | 4.9M |
AKAN | Akanda | 0% | 2.3M |
You can purchase shares of Kiora Pharmaceuticals (NASDAQ: KPRX) through any online brokerage.
Other companies in Kiora Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN) and Jaguar Health (NASDAQ:JAGX).
The latest price target for Kiora Pharmaceuticals (NASDAQ: KPRX) was reported by HC Wainwright & Co. on Thursday, August 24, 2023. The analyst firm set a price target for 2.00 expecting KPRX to rise to within 12 months (a possible 263.64% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $0.55 last updated September 20, 2023 at 7:59 PM UTC.
There is no dividend information for Kiora Pharmaceuticals.
Kiora Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Kiora Pharmaceuticals.
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Kiora Pharmaceuticals Stock (NASDAQ: KPRX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.30.000 / 331.941K | Mkt Cap3.986M |
Day Range- - - | 52 Wk Range0.462 - 10.390 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.060 | -0.790 | 0.2700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-24 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-08-14 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Lowers | 7.00 | 2.00 |
2023-08-09 | Maxim Group | Michael Okunewitch | Maintains | BuyBuy | Lowers | 12.00 | 2.00 |
2023-05-12 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Raises | 6.00 | 7.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
KPRX | Kiora Pharmaceuticals | 0% | 4M |
BXRX | Baudax Bio | 0% | 3.1M |
SXTP | 60 Degrees | 0% | 4.9M |
UPC | Universe Pharmaceuticals | 0% | 4.9M |
AKAN | Akanda | 0% | 2.3M |
You can purchase shares of Kiora Pharmaceuticals (NASDAQ: KPRX) through any online brokerage.
Other companies in Kiora Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN) and Jaguar Health (NASDAQ:JAGX).
The latest price target for Kiora Pharmaceuticals (NASDAQ: KPRX) was reported by HC Wainwright & Co. on Thursday, August 24, 2023. The analyst firm set a price target for 2.00 expecting KPRX to rise to within 12 months (a possible 263.64% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $0.55 last updated September 20, 2023 at 7:59 PM UTC.
There is no dividend information for Kiora Pharmaceuticals.
Kiora Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Kiora Pharmaceuticals.
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Kiora Pharmaceuticals Stock (NASDAQ: KPRX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.30.000 / 331.941K | Mkt Cap3.986M |
Day Range- - - | 52 Wk Range0.462 - 10.390 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.060 | -0.790 | 0.2700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-24 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-08-14 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Lowers | 7.00 | 2.00 |
2023-08-09 | Maxim Group | Michael Okunewitch | Maintains | BuyBuy | Lowers | 12.00 | 2.00 |
2023-05-12 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Raises | 6.00 | 7.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
KPRX | Kiora Pharmaceuticals | 0% | 4M |
BXRX | Baudax Bio | 0% | 3.1M |
SXTP | 60 Degrees | 0% | 4.9M |
UPC | Universe Pharmaceuticals | 0% | 4.9M |
AKAN | Akanda | 0% | 2.3M |
You can purchase shares of Kiora Pharmaceuticals (NASDAQ: KPRX) through any online brokerage.
Other companies in Kiora Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN) and Jaguar Health (NASDAQ:JAGX).
The latest price target for Kiora Pharmaceuticals (NASDAQ: KPRX) was reported by HC Wainwright & Co. on Thursday, August 24, 2023. The analyst firm set a price target for 2.00 expecting KPRX to rise to within 12 months (a possible 263.64% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $0.55 last updated September 20, 2023 at 7:59 PM UTC.
There is no dividend information for Kiora Pharmaceuticals.
Kiora Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Kiora Pharmaceuticals.
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Kiora Pharmaceuticals Stock (NASDAQ: KPRX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.30.000 / 331.941K | Mkt Cap3.986M |
Day Range- - - | 52 Wk Range0.462 - 10.390 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.060 | -0.790 | 0.2700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-24 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-08-14 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Lowers | 7.00 | 2.00 |
2023-08-09 | Maxim Group | Michael Okunewitch | Maintains | BuyBuy | Lowers | 12.00 | 2.00 |
2023-05-12 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Raises | 6.00 | 7.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
KPRX | Kiora Pharmaceuticals | 0% | 4M |
BXRX | Baudax Bio | 0% | 3.1M |
SXTP | 60 Degrees | 0% | 4.9M |
UPC | Universe Pharmaceuticals | 0% | 4.9M |
AKAN | Akanda | 0% | 2.3M |
You can purchase shares of Kiora Pharmaceuticals (NASDAQ: KPRX) through any online brokerage.
Other companies in Kiora Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN) and Jaguar Health (NASDAQ:JAGX).
The latest price target for Kiora Pharmaceuticals (NASDAQ: KPRX) was reported by HC Wainwright & Co. on Thursday, August 24, 2023. The analyst firm set a price target for 2.00 expecting KPRX to rise to within 12 months (a possible 263.64% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $0.55 last updated September 20, 2023 at 7:59 PM UTC.
There is no dividend information for Kiora Pharmaceuticals.
Kiora Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Kiora Pharmaceuticals.
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Kiora Pharmaceuticals Stock (NASDAQ: KPRX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.30.000 / 331.941K | Mkt Cap3.986M |
Day Range- - - | 52 Wk Range0.462 - 10.390 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.060 | -0.790 | 0.2700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-24 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-08-14 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Lowers | 7.00 | 2.00 |
2023-08-09 | Maxim Group | Michael Okunewitch | Maintains | BuyBuy | Lowers | 12.00 | 2.00 |
2023-05-12 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Raises | 6.00 | 7.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
KPRX | Kiora Pharmaceuticals | 0% | 4M |
BXRX | Baudax Bio | 0% | 3.1M |
SXTP | 60 Degrees | 0% | 4.9M |
UPC | Universe Pharmaceuticals | 0% | 4.9M |
AKAN | Akanda | 0% | 2.3M |
You can purchase shares of Kiora Pharmaceuticals (NASDAQ: KPRX) through any online brokerage.
Other companies in Kiora Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN) and Jaguar Health (NASDAQ:JAGX).
The latest price target for Kiora Pharmaceuticals (NASDAQ: KPRX) was reported by HC Wainwright & Co. on Thursday, August 24, 2023. The analyst firm set a price target for 2.00 expecting KPRX to rise to within 12 months (a possible 263.64% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $0.55 last updated September 20, 2023 at 7:59 PM UTC.
There is no dividend information for Kiora Pharmaceuticals.
Kiora Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Kiora Pharmaceuticals.
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Kiora Pharmaceuticals Stock (NASDAQ: KPRX) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.30.000 / 331.941K | Mkt Cap3.986M |
Day Range- - - | 52 Wk Range0.462 - 10.390 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.060 | -0.790 | 0.2700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-24 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-08-14 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Lowers | 7.00 | 2.00 |
2023-08-09 | Maxim Group | Michael Okunewitch | Maintains | BuyBuy | Lowers | 12.00 | 2.00 |
2023-05-12 | HC Wainwright & Co. | Yi Chen | Maintains | BuyBuy | Raises | 6.00 | 7.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
KPRX | Kiora Pharmaceuticals | 0% | 4M |
BXRX | Baudax Bio | 0% | 3.1M |
SXTP | 60 Degrees | 0% | 4.9M |
UPC | Universe Pharmaceuticals | 0% | 4.9M |
AKAN | Akanda | 0% | 2.3M |
You can purchase shares of Kiora Pharmaceuticals (NASDAQ: KPRX) through any online brokerage.
Other companies in Kiora Pharmaceuticals’s space includes: Baudax Bio (NASDAQ:BXRX), 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN) and Jaguar Health (NASDAQ:JAGX).
The latest price target for Kiora Pharmaceuticals (NASDAQ: KPRX) was reported by HC Wainwright & Co. on Thursday, August 24, 2023. The analyst firm set a price target for 2.00 expecting KPRX to rise to within 12 months (a possible 263.64% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $0.55 last updated September 20, 2023 at 7:59 PM UTC.
There is no dividend information for Kiora Pharmaceuticals.
Kiora Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Kiora Pharmaceuticals.
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.